Morgan Stanley Direct Lending Fund current report, 28 July 2022

Morgan Stanley Direct Lending Fund — Form 8-K Summary

Business Context and Reporting Period

The Form 8-K was filed on August 1, 2022, reporting events occurring on or before July 28, 2022. The filing covers a reduction in the Company’s revolving credit commitment and an $80 million capital drawdown from stockholders.

Key Financial and Capital Structure Information

  • Revolving credit commitment: Reduced from $280 million to $235 million, effective July 28, 2022.
  • Debt facility terms: The filing states that all other terms of the Credit Facility remained unchanged.
  • Equity issuance: Approximately 3,911,980 shares of common stock were sold for an aggregate offering price of $80 million.
  • Implied offering price: Approximately $20.45 per share, based on the stated aggregate proceeds and share count.
  • Closing date: The equity sale closed on July 28, 2022.
  • Financial results and liquidity metrics: The filing does not provide revenue, profit, cash flow, margins, net asset value, debt outstanding, or cash balances.

Material Changes Versus the Prior Comparable Period

  • The revolving commitment decreased by $45 million, or approximately 16.1%, from $280 million to $235 million.
  • The Company raised $80 million through a capital drawdown under existing stockholder subscription agreements.

Guidance, Outlook, Risks, and Unusual Items

  • The filing provides no earnings guidance or broader business outlook.
  • Stockholders are required to fund drawdowns up to their respective capital commitments on an as-needed basis, with at least eight business days’ prior notice.
  • The common stock issuance was conducted without registration under Section 4(a)(2) of the Securities Act and Regulation D, based in part on stockholder representations that investors were accredited investors.
  • The filing does not identify new credit facility pricing, covenant changes, defaults, contingencies, or other unusual items.

Important Facts for Investors to Verify

  1. Confirm the effective reduction of the revolving commitment to $235 million and review the filed commitment-reduction letter.
  2. Verify the final number of shares issued, aggregate proceeds, and applicable subscription and capital commitment terms.
  3. Assess the effect of the reduced borrowing capacity on portfolio funding and liquidity.
  4. Review subsequent filings for additional capital drawdowns, changes in debt terms, and financial performance data.